New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 15, 2019 - Noven Pharmaceuticals announced the FDA approval of Secuado (asenapine), for the treatment of adults with schizophrenia..
Download PDF
Return to publications
